Fat composition and nutritional composition based thereon

US12544405B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12544405-B2
Application numberUS-202017431957-A
CountryUS
Kind codeB2
Filing dateFeb 27, 2020
Priority dateMar 1, 2019
Publication dateFeb 10, 2026
Grant dateFeb 10, 2026

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention relates to a fat composition and a nutritional composition comprising such fat composition. The nutritional composition is particularly suitable for therapeutic applications in treating gut discomfort and/or constipation as well as in non-therapeutic applications for reducing the intestinal formation of calcium and magnesium fatty acid soaps. The fat composition comprises a mixture of triacylglycerols (TAG) originating from a bovine milk fat source and a vegetable lipid source, said mixture being characterized by: (a) a content of butanoate groups (C4:0) of 0.5-2.8% by weight based on total weight of fatty acid acyl groups in TAG; (b) a wLCSFA(sn-1,3) of 18.0-35.0% by weight; (c) a mLCFA (sn-1,3) of 48.0-61.0 mol %; and (d) a ratio mLCFA (sn-1,3)/SFA of 0.70-1.25, wherein: —LCFA(sn-1,3) are the long chain fatty acid acyl groups having a chain length of 12 or more carbon atoms at the sn-1 and sn-3 position in TAG; —LCSFA(sn-1,3) are the long chain saturated fatty acid acyl groups having a chain length of 12 or more carbon atoms at the sn-1 and sn-3 position in TAG; —wLCSFA(sn-1,3) is the amount of LCFA(sn-1,3) in % by weight based on total weight of fatty acid acyl groups in TAG; —mLCFA(sn-1,3) is the mole fraction of LCFA(sn-1,3) based on total moles of fatty acid acyl groups in the TAG as expressed in mol %; and—SFA is the mole fraction of saturated fatty acid acyl groups in the TAG as expressed in mol %.

First claim

Opening claim text (preview).

The invention claimed is: 1 . A fat composition comprising a mixture of triacylglycerols (TAG) originating from a bovine milk fat source and a vegetable lipid source, said mixture comprising: (a) a content of butanoate groups (C4:0) of 0.5-2.8% by weight, based on total weight of fatty acid acyl groups in TAG; (b) a wLCSFA(sn-1,3) of 18.0-35.0% by weight; (c) a mLCFA (sn-1,3) of 48.0-61.0 mol %, preferably 50.0-59.0 mol %; and (d) a ratio mLCFA (sn-1,3)/SFA of 0.70-1.25, wherein: LCFA(sn-1,3) are the long chain fatty acid acyl groups having a chain length of 12 or more carbon atoms at the sn-1 and sn-3 position in TAG; LCSFA(sn-1,3) are the long chain saturated fatty acid acyl groups having a chain length of 12 or more carbon atoms at the sn-1 and sn-3 position in TAG; wLCSFA(sn-1,3) is the amount of LCSFA(sn-1,3) in % by weight based on total weight of fatty acid acyl groups in TAG; mLCFA(sn-1,3) is the mole fraction of LCFA(sn-1,3) based on total moles of fatty acid acyl groups in the TAG as expressed in mol %; and SFA is the mole fraction of saturated fatty acid acyl groups in the TAG as expressed in mol %. 2 . The fat composition according to claim 1 , wherein: the content of butanoate groups (C4:0) is 0.5-2.2% by weight, based on total weight of fatty acid acyl groups in TAG; and the ratio mLCFA (sn-1,3)/SFA is 0.95-1.25. 3 . The fat composition according to claim 1 comprising 10-60 wt %, based on total weight of TAG, of TAG originating from the bovine milk fat source. 4 . The fat composition according to claim 3 , wherein the bovine milk fat source is whole milk and/or cream. 5 . A nutritional composition comprising proteins, carbohydrates and a lipid source, wherein the lipid source comprises the fat composition according to claim 1 . 6 . The nutritional composition according to claim 5 , wherein the nutritional composition has a ratio mLCFA ⁡ ( sn - 1 , 3 ) * ( Ca + Mg ) SFA in the range of 0.40 to 0.75 grams per 100 grams of nutritional composition (g/100 g), wherein (Ca+Mg) is a concentration of calcium plus a concentration of magnesium in the nutritional composition in g/100 g. 7 . A method of treating gut discomfort and/or constipation in a subject, the method comprising administering to the subject an effective amount of the nutritional composition of claim 5 , wherein the subject is a human subject of 0-36 months of age. 8 . A method of reducing intestinal formation of calcium and magnesium fatty acid soaps in a subject, the method comprising administering to the subject an effective amount of the nutritional composition of claim 5 . 9 . A method of treating gut discomfort and/or constipation in a subject, the method comprising administering to the subject an effective amount of the fat composition of claim 1 , wherein the subject is a human subject of 0-36 months of age. 10 . A method of reducing intestinal formation of calcium and magnesium fatty acid soaps in a subject, the method comprising administering to the subject an effective amount of the fat composition of claim 1 . 11 . The fat composition according to claim 1 , wherein the content of butanoate groups (C4:0) in the mixture is 0.6-2.7% by weight, based on total weight of fatty acid acyl groups in TAG. 12 . The fat composition according to claim 1 , wherein the content of butanoate groups (C4:0) in the mixture is 0.6-2.0% by weight, based on total weight of fatty acid acyl groups in TAG. 13 . The fat composition according to claim 1 , wherein the wLCSFA (sn-1,3) of the mixture is 19.0-32.0% by weight. 14 . The fat composition according to claim 1 , wherein the mLCFA (sn-1,3) of the mixture is 50.0-59.0 mol %. 15 . The fat composition according to claim 1 , wherein the ratio mLCFA (sn-1,3)/SFA is 0.80-1.20. 16 . The fat composition according to claim 1 , wherein the ratio mLCFA (sn-1,3)/SFA is 1.00-1.20.

Assignees

Inventors

Classifications

  • of acids having a carboxyl group bound to a chain of seven or more carbon atoms · CPC title

  • Food compositions, function of food ingredients or processes for food or foodstuffs · CPC title

  • Other edible oils or fats, e.g. shortenings or cooking oils (preservation of other edible oils A23B20/30) · CPC title

  • Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents · CPC title

  • Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12544405B2 cover?
The invention relates to a fat composition and a nutritional composition comprising such fat composition. The nutritional composition is particularly suitable for therapeutic applications in treating gut discomfort and/or constipation as well as in non-therapeutic applications for reducing the intestinal formation of calcium and magnesium fatty acid soaps. The fat composition comprises a mixtur…
Who is the assignee on this patent?
Frieslandcampina Nederland Bv
What technology area does this patent fall under?
Primary CPC classification A23L33/115. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Feb 10 2026 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).